Press

IN THE NEWS

December 2023

Millipede 070 Aspriation & 2nd gen Millipede...

FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment

READ MORE
November 2023

PRESENTED POSTER - SVIN 2023

First-in-Human Experience Using Millipede 088 Aspiration Catheter in Stroke Thrombectomy

Read More
November 2023

MARRS Trial: 1st Patient Enrolled

First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial at StonyBrook

Read More
June 2023

LATE BREAKING ABSTRACT - SNIS 2023

Multi-center Experience Using the Millipede 088 Superboare Catehter in Stroke Thrombectomy

Read More
June 2023

Perfuze Announces Appointment of New Chair of...

Hooman Hakami named new Chair of the Board

Read More
February 2023

Millipede 088 Access Catheter

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter

Read More
March 2022

Neurovascular Company Perfuze Raises €22.5m...

Series A for New Stroke Treatment. Perfuze Raises €22.5m

Read More
May 2021

Perfuze secures CE Mark on first product

First five patients successfully treated

Read More
March 2021

Published paper - JNIS

Millipede 088 optimizes distal flow control resulting in potential improved revascularization rates

Read more
December 2020

Perfuze wins €4.4m DTIF Grant

Minister Humphreys announces €65m for 16 ground-breaking projects

Read more